Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07385443Recruiting

The Spanish National Registry for Myotonic Dystrophy Type 1

Role: collaborator

NCT07336550Not ApplicableNot Yet Recruiting

Reduction of Low-value Prescribing Through Audit and Feedback

Role: collaborator

NCT06448182Not ApplicableRecruiting

Effect of a Postbiotic Intake on Glucose Control and Microbiota Composition of Type 2 Diabetic Subjects: a Randomized Controlled Trial.

Role: collaborator

NCT06499376Completed

Clinical Deterioration Early Warning System Score

Role: collaborator

All 4 trials loaded